Rising Pharmaceuticals Recalls Timolol Maleate Ophthalmic Solution Due to Labeling Error
Rising Pharmaceuticals is recalling 15,072 bottles of Timolol Maleate 0.25% ophthalmic solution because some outer cartons were mislabeled as 0.5% strength.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The hazard is a minor labeling error where the outer carton strength did not match the bottle, but the bottle itself was correctly labeled and contained the correct medication.
Plain-English summary
Rising Pharmaceuticals, Inc. is recalling 15,072 bottles of Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5 mL, NDC 64980-513-05. The recall was initiated due to a labeling mix-up where the outer carton for the 0.25% strength product was mistakenly labeled as the 0.5% strength product, while the bottle inside contained the correct 0.25% solution.
The affected product is distributed nationwide in the U.S.A. The specific lot number is 089A016, with an expiration date of 12/2020. The product is a prescription-only ophthalmic solution manufactured by FDC Limited in India and distributed by Rising Pharmaceuticals, Inc. in Saddle Brook, NJ.
Consumers and healthcare providers should check their inventory for this specific lot and NDC number. If the outer carton indicates 0.5% strength but the bottle indicates 0.25%, the product should be returned to the distributor or disposed of according to local regulations. No adverse health consequences are expected from this labeling error, as the actual medication strength in the bottle matches the bottle label.
The recalled product
- Product
- TIMOLOL MALEATE (TIMOLOL MALEATE)
- Brand
- TIMOLOL MALEATE
- Manufacturer
- Rising Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic Solution
- Hazard
- Affected units
- 15,072
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 089A016
- Exp 12/2020
UPCs (2)
- 0364980513050
- 0364980514057
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Rising Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · TIMOLOL MALEATE
- ModerateTimolol eye drop caps can lodge a spike in the nozzle
FDA (Drugs) · 2025-08-06
- ModerateTimolol Maleate Ophthalmic Solution Recalled for Defective Container
FDA (Drugs) · 2025-05-14
- ModerateTimolol Maleate eye drops recalled for defective dropper cap
FDA (Drugs) · 2025-02-12
- HighOphthalmic Eye Drops Recalled for Defective Container Cap Spike
FDA (Drugs) · 2024-12-18
- HighTimolol Maleate Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2024-11-13
Same manufacturer · Rising Pharmaceuticals, Inc.
See all →- LowRising Pharmaceuticals Recalls Timolol Maleate Ophthalmic Solution Due to Labeling Error
FDA (Drugs) · 2020-07-01
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereRising Pharmaceuticals Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02